AstraZeneca
The Medical Science Liaison (MSL) is a field‑based scientific expert who supports the medical and scientific objectives of Alexion/AstraZeneca Rare Disease products across their lifecycle. The role involves building and managing relationships with healthcare practitioners and key opinion leaders, providing scientific information, gathering insights, and supporting research initiatives within the NYC/Long Island region.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
57% above the average for this role
Senior Medical Science Liaison, Rare Neurology, NYC/Long Island
lifelancer
Medical Science Liaison, Rare Neurology, Northeast
lifelancer
Sr. Medical Science Liaison (MSL)
UCB
Medical Science Liaison
Pharvaris
LSD Medical Science Liaison (MSL)
biomarin
Senior Medical Science Liaison (MSL), Rare Disease - West
Acadia Pharmaceuticals Inc.